Disease Information for Tarlafil (Cialis) Administration/Toxicity

Ads
Associated Diseases & Rule outs
Associated Disease & Complications
Drug induced Orthostatic hypotension
Orthostatic hypotension syndrome
Priapism/persistent erection
Disease Synergy - Causes
Synergy/Nitrates long acting
Disease Mechanism & Classification
Drugs
DRUG/Anti-Erectile dysfunction/impotence medication
DRUG/Phosphodiesterase type 5 inhibitor (cGMP)
DRUG-New drugs (listed only)
Pathophysiology
Pathophysiology/Anti-prostaglandin PG-5/Penile effect
Process
PROCESS/Medication/Drug (CONFIRM dose/before treatment)
Synonyms
Synonym
Tarlafil (Cialis) administration, Brand name/Cialis (Tadalafil)
Treatment
Drug Dosage
DRUG/Dose 10 mgm (Unit/Pill/Capsule size)
DRUG/Dose 20 mgm (Unit/Pill/Capsule size)
DRUG/Dose 5 mgm (Unit/Pill/Capsule size)
DRUG/Dose One time
DRUG/Foreign license drug (non-USA)
DRUG/Half-life relatively long
DRUG/Not available USA/medication
DRUG/Oral medication (ex)
Definition

Anti-PDE5 or Phospho-diesterase type 5 inhibitor drug for Erectile disorder/impotence; activity like sildenafil (viagra); oral preparation longer acting; Europe release 2003; Release 2004 in USA

(Edit)

External Links Related to Tarlafil (Cialis) Administration/Toxicity
Google
Wikipedia
Merck
Images
PubMed (National Library of Medicine)
NGC (National Guideline Clearinghouse)
Medscape (eMedicine)
Harrison's Online (accessmedicine)
NEJM (The New England Journal of Medicine)
Ads